|
1
|
Withrow SJ, Vail DM and Page RL: Withrow
and MacEwen's small animal clinical oncology. 5th. Elsevier; St.
Louis, MI: 2013, View Article : Google Scholar
|
|
2
|
Patnaik AK, Hurvitz AI, Lieberman PH and
Johnson GF: Canine hepatocellular carcinoma. Vet Pathol.
18:427–438. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liptak JM, Dernell WS, Monnet E, Powers
BE, Bachand AM, Kenney JG and Withrow SJ: Massive hepatocellular
carcinoma in dogs: 48 cases (1992–2002). J Am Vet Med Assoc.
225:1225–1230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weisse C, Clifford CA, Holt D and Solomon
JA: Percutaneous arterial embolization and chemoembolization for
treatment of benign and malignant tumors in three dogs and a goat.
J Am Vet Med Assoc. 221:1430–1436, 1419. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ginn PE: Immunohistochemical detection of
P-glycoprotein in formalin-fixed and paraffin-embedded normal and
neoplastic canine tissues. Vet Pathol. 33:533–541. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ogilvie GK, Obradovich JE, Elmslie RE,
Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF and Withrow SJ:
Efficacy of mitoxantrone against various neoplasms in dogs. J Am
Vet Med Assoc. 198:1618–1621. 1991.PubMed/NCBI
|
|
7
|
Moore AS and Kitchell BE: New chemotherapy
agents in veterinary medicine. Vet Clin North Am Small Anim Pract.
33:629–649. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elpiner AK, Brodsky EM, Hazzah TN and Post
GS: Single-agent gemcitabine chemotherapy in dogs with
hepatocellular carcinomas. Vet Comp Oncol. 9:260–268. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma S, Lee TK, Zheng BJ, Chan KW and Guan
XY: CD133+ HCC cancer stem cells confer chemoresistance by
preferential expression of the Akt/PKB survival pathway. Oncogene.
27:1749–1758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of CD90+ cancer
stem cells in human liver cancer. Cancer Cell. 13:153–166. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Endo K and Terada T: Protein expression of
CD44 (standard and variant isoforms) in hepatocellular carcinoma:
Relationships with tumor grade, clinicopathologic parameters, p53
expression, and patient survival. J Hepatol. 32:78–84. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Michishita M, Ezaki S, Ogihara K, Naya Y,
Azakami D, Nakagawa T, Sasaki N, Arai T, Shida T and Takahashi K:
Identification of tumor-initiating cells in a canine hepatocellular
carcinoma cell line. Res Vet Sci. 96:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cogliati B, Aloia TP, Bosch RV, Alves VA,
Hernandez-Blazquez FJ and Dagli ML: Identification of hepatic
stem/progenitor cells in canine hepatocellular and
cholangiocellular carcinoma. Vet Comp Oncol. 8:112–121. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ronot X, Benel L, Adolphe M and Mounolou
JC: Mitochondrial analysis in living cells: The use of rhodamine
123 and flow cytometry. Biol Cell. 57:1–7. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McKenzie JL, Takenaka K, Gan OI, Doedens M
and Dick JE: Low rhodamine 123 retention identifies long-term human
hematopoietic stem cells within the LinCD34+CD38 population. Blood.
109:543–545. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bussolati B, Bruno S, Grange C, Ferrando U
and Camussi G: Identification of a tumor-initiating stem cell
population in human renal carcinomas. FASEB J. 22:3696–3705. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCq method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Johnson LV, Walsh ML and Chen LB:
Localization of mitochondria in living cells with rhodamine 123.
Proc Natl Acad Sci USA. 77:pp. 990–994. 1980; View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harman D: Aging: A theory based on free
radical and radiation chemistry. J Gerontol. 11:298–300. 1956.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wagner-Souza K, Diamond HR, Ornellas MH,
Gomes BE, Almeida-Oliveira A, Abdelhay E, Bouzas LF and Rumjanek
VM: Rhodamine 123 efflux in human subpopulations of hematopoietic
stem cells: Comparison between bone marrow, umbilical cord blood
and mobilized peripheral blood CD34+ cells. Int J Mol Med.
22:237–242. 2008.PubMed/NCBI
|
|
26
|
Lu J, Cui Y, Zhu J, He J, Zhou G and Yue
Z: Biological characteristics of Rh123 (high) stem-like cells in a
side population of 786-O renal carcinoma cells. Oncol Lett.
5:1903–1908. 2013.PubMed/NCBI
|
|
27
|
Vu NB, Nguyen TT, Tran LC, Do CD, Nguyen
BH, Phan NK and Pham PV: Doxorubicin and 5-fluorouracil resistant
hepatic cancer cells demonstrate stem-like properties.
Cytotechnology. 65:491–503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu LB and Liu C: Role of liver stem cells
in hepatocarcinogenesis. World J Stem Cells. 6:579–590. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wilson H, Huelsmeyer M, Chun R, Young KM,
Friedrichs K and Argyle DJ: Isolation and characterisation of
cancer stem cells from canine osteosarcoma. Vet J. 175:69–75. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Penzo C, Ross M, Muirhead R, Else R and
Argyle DJ: Effect of recombinant feline interferon-omega alone and
in combination with chemotherapeutic agents on putative
tumour-initiating cells and daughter cells derived from canine and
feline mammary tumours. Vet Comp Oncol. 7:222–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stoica G, Lungu G, Martini-Stoica H,
Waghela S, Levine J and Smith R III: Identification of cancer stem
cells in dog glioblastoma. Vet Pathol. 46:391–406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu W, Selçuk F, Rütgen BC, Moulay M,
Willenbrock S, Hammer SE, Sterenczak KA, Junghanss C,
Hewicker-Trautwein M, Nolte I, et al: Evaluation of stem cell
marker expression in canine B-cell lymphoma cell lines, B-cell
lymphoma-generated spheres and primary samples. Anticancer Res.
35:2805–2816. 2015.PubMed/NCBI
|
